Concepedia
Statistics
Publications
3
Citations
57
H-Index
Active since
2020
Affiliations
KTH Royal Institute of Technology(Current)
Uppsala University
National Research Tomsk State University
Tomsk Polytechnic University
Hanna Tano is an author at KTH Royal Institute of Technology specializing in pharmacology, targeted radionuclide therapy, and oncology.
Publications per year
2020–2021
Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts
Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva et al. · Journal of Nuclear Medicine · 2021 · 23 citations · Full text
Medicine, Oncology, Pharmacology +17
Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
Hanna Tano, Maryam Oroujeni, Anzhelika Vorobyeva et al. · Cancers · 2021 · 20 citations · Full text
Medicine, Oncology, Pharmacology +16
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
Ayman Abouzayed, Hanna Tano, Ábel Nagy et al. · Pharmaceutics · 2020 · 14 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
1–3 of 3